Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals

Most important quality attributes of any radiopharmaceutical (RPh) are its radiochemical purity (RCP) or content of radiochemical impurities (RCIs) that have to comply with respective norms and limits. However, at present, there is no unified approach to validation of analytical methods in the conte...

Full description

Bibliographic Details
Main Authors: A. O. Malysheva, G. E. Kodina, E. A. Lyamtseva, N. A. Taratonenkova, A. S. Lunev
Format: Article
Language:Russian
Published: NEICON ISP LLC 2020-12-01
Series:Ведомости Научного центра экспертизы средств медицинского применения
Subjects:
Online Access:https://www.vedomostincesmp.ru/jour/article/view/313
_version_ 1797199056239329280
author A. O. Malysheva
G. E. Kodina
E. A. Lyamtseva
N. A. Taratonenkova
A. S. Lunev
author_facet A. O. Malysheva
G. E. Kodina
E. A. Lyamtseva
N. A. Taratonenkova
A. S. Lunev
author_sort A. O. Malysheva
collection DOAJ
description Most important quality attributes of any radiopharmaceutical (RPh) are its radiochemical purity (RCP) or content of radiochemical impurities (RCIs) that have to comply with respective norms and limits. However, at present, there is no unified approach to validation of analytical methods in the context of highly radioactive samples.The aim of the study was to develop an approach to validation of methods for determination of RCI content in RPhs.Materials and methods: the authors determined the content of RCIs in a radiopharmaceutical formulation containing a complex of technetium-99m and methylenediphosphonic acid by the radiometric method after isolation of impurities from the main compound by thin-layer chromatography using silica gel and methyl ethyl ketone (for sodium pertechnetate determination) and silica gel and 13.6% sodium acetate solution (for determination of hydrolysed reduced technetium-99m). The radioactivity was registered by a chromatogram scanner with a detector of gamma-rays with energies from 0.05 to 1.5 MeV.Results: the paper analyses existing official approaches to validation of analytical procedures and compares them with the results of experimental studies described in available publications. It assesses the validation parameters for compliance with the acceptance criteria set forth in the current regulations and substantiates selectivity of chromatographic determination of impurities under the selected test conditions. Coefficients of variation for repeatability, reproducibility, and accuracy did not exceed 4.5, 2.8, and 8.9%, respectively, given the relative error of not more than 10.5%. The study demonstrated signal linearity for the 10-fold dilution of the standardised sodium pertechnetate solution, it also demonstrated correspondence between the applied and detected radioactivity when performing the test in the impurity content range of 0.5–5%. The validation procedure was associated with significant radiation burden for the personnel of the quality control laboratory.Conclusions: the authors suggested a methodological approach to validation of methods for determination of RCI content in technetium-99m-based RPhs. This approach may be used in the development of a guideline on validation of analytical methods for RCP/RCI determination in RPhs, or for introduction of relevant sections into existing documents.
first_indexed 2024-03-07T19:18:02Z
format Article
id doaj.art-5a69081635b04ece8004711e5e552019
institution Directory Open Access Journal
issn 1991-2919
2619-1172
language Russian
last_indexed 2024-04-24T07:09:41Z
publishDate 2020-12-01
publisher NEICON ISP LLC
record_format Article
series Ведомости Научного центра экспертизы средств медицинского применения
spelling doaj.art-5a69081635b04ece8004711e5e5520192024-04-21T11:46:34ZrusNEICON ISP LLCВедомости Научного центра экспертизы средств медицинского применения1991-29192619-11722020-12-0110424425610.30895/1991-2919-2020-10-4-244-256246Experience in Validation of Methods for Determination of Radiochemical Impurities in RadiopharmaceuticalsA. O. Malysheva0G. E. Kodina1E. A. Lyamtseva2N. A. Taratonenkova3A. S. Lunev4State Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyState Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyState Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyState Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyState Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyMost important quality attributes of any radiopharmaceutical (RPh) are its radiochemical purity (RCP) or content of radiochemical impurities (RCIs) that have to comply with respective norms and limits. However, at present, there is no unified approach to validation of analytical methods in the context of highly radioactive samples.The aim of the study was to develop an approach to validation of methods for determination of RCI content in RPhs.Materials and methods: the authors determined the content of RCIs in a radiopharmaceutical formulation containing a complex of technetium-99m and methylenediphosphonic acid by the radiometric method after isolation of impurities from the main compound by thin-layer chromatography using silica gel and methyl ethyl ketone (for sodium pertechnetate determination) and silica gel and 13.6% sodium acetate solution (for determination of hydrolysed reduced technetium-99m). The radioactivity was registered by a chromatogram scanner with a detector of gamma-rays with energies from 0.05 to 1.5 MeV.Results: the paper analyses existing official approaches to validation of analytical procedures and compares them with the results of experimental studies described in available publications. It assesses the validation parameters for compliance with the acceptance criteria set forth in the current regulations and substantiates selectivity of chromatographic determination of impurities under the selected test conditions. Coefficients of variation for repeatability, reproducibility, and accuracy did not exceed 4.5, 2.8, and 8.9%, respectively, given the relative error of not more than 10.5%. The study demonstrated signal linearity for the 10-fold dilution of the standardised sodium pertechnetate solution, it also demonstrated correspondence between the applied and detected radioactivity when performing the test in the impurity content range of 0.5–5%. The validation procedure was associated with significant radiation burden for the personnel of the quality control laboratory.Conclusions: the authors suggested a methodological approach to validation of methods for determination of RCI content in technetium-99m-based RPhs. This approach may be used in the development of a guideline on validation of analytical methods for RCP/RCI determination in RPhs, or for introduction of relevant sections into existing documents.https://www.vedomostincesmp.ru/jour/article/view/313radiopharmaceuticalvalidationpharmacopoeiaradionuclidetechnetium-99mradiochemical impuritiesquality controlequivalent dose
spellingShingle A. O. Malysheva
G. E. Kodina
E. A. Lyamtseva
N. A. Taratonenkova
A. S. Lunev
Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
Ведомости Научного центра экспертизы средств медицинского применения
radiopharmaceutical
validation
pharmacopoeia
radionuclide
technetium-99m
radiochemical impurities
quality control
equivalent dose
title Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
title_full Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
title_fullStr Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
title_full_unstemmed Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
title_short Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
title_sort experience in validation of methods for determination of radiochemical impurities in radiopharmaceuticals
topic radiopharmaceutical
validation
pharmacopoeia
radionuclide
technetium-99m
radiochemical impurities
quality control
equivalent dose
url https://www.vedomostincesmp.ru/jour/article/view/313
work_keys_str_mv AT aomalysheva experienceinvalidationofmethodsfordeterminationofradiochemicalimpuritiesinradiopharmaceuticals
AT gekodina experienceinvalidationofmethodsfordeterminationofradiochemicalimpuritiesinradiopharmaceuticals
AT ealyamtseva experienceinvalidationofmethodsfordeterminationofradiochemicalimpuritiesinradiopharmaceuticals
AT nataratonenkova experienceinvalidationofmethodsfordeterminationofradiochemicalimpuritiesinradiopharmaceuticals
AT aslunev experienceinvalidationofmethodsfordeterminationofradiochemicalimpuritiesinradiopharmaceuticals